The federal judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma set a June 30 deadline to file claims against the company.
By Geoff Mulvihill, Associated Press
Massachusetts is the only state in the country where men who are involuntarily committed for substance abuse treatment can be treated in jails.
By Sam Weber
The manufacturers and distributors of opioid prescription painkillers have supplied billions of pills throughout the U.S. An investigative series by The Washington Post looks at the opioid epidemic through the DEA's newly public database that tracks every pain pill sold…
Over the past two decades, hundreds of thousands of Americans have died during a national opioid addiction crisis. As the drug manufacturers face a possible legal reckoning from multiple lawsuits, a newly uncovered database sheds more light on the scope…
By Associated Press
The measure is modeled after a Miami-based program which also provides HIV screening, access to social services, the opioid-overdose antidote Narcan and other medical supplies.
By Elana Schor, Associated Press
The Massachusetts senator and Democratic presidential candidate released her new plan Wednesday ahead of a campaign trip to Ohio and West Virginia, where she'll visit a town that sued drug companies.
Amid the ongoing opioid epidemic, drug manufacturers, doctors and pharmacists have all come under fire. But it's a drug distributor, a company called RDC, at the center of a new federal criminal case that equates its business operations with illegal…
By Dan Sewell, Associated Press
It's what federal authorities are calling the biggest known takedown yet of drug prescribers, which includes 31 doctors charged for their roles in illegally prescribing and distributing millions of pills containing opioids and other dangerous drugs.
By Laura Santhanam
Here's a breakdown of how significant the $270 million settlement is in the context of the nation's continued struggle with opioids, overdoses and need for harm reduction and treatment.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.